Midi Health announced it raised $100 million in a Series D financing round that values the women’s telehealth company at over $1 billion, as it expands beyond perimenopause and menopause care into a broader, AI-enabled platform for women across life stages.
The Palo Alto-based company said the round was led by Goodwater Capital and included new participation from Foresite Capital and Serena Ventures, alongside continued support from Advance Venture Partners, GV (Google Ventures), Emerson Collective, SemperVirens, McKesson Ventures, and Felicis Ventures.
Midi was founded to address gaps in women’s care that the company said carry significant health and economic costs. The company cited estimates that 2 million U.S. women enter menopause each year and that untreated symptoms cost about $25 billion annually in medical expenses and lost productivity, adding that closing women’s health gaps across the lifespan could contribute nearly $295 billion to the U.S. economy by 2040.
Midi said it has grown into a nationwide platform with insurance coverage reaching more than 45 million women. The company said more than 25,000 patients use Midi each week for care spanning OB-GYN, internal medicine, cardiology, endocrine, survivorship, obesity, sleep, mood disorders, dermatology, longevity, naturopathic medicine, and other specialties.
The company said AI supports clinical decision-making and reduces operational strain, with its proprietary AI engine focused on personalizing care through chart analysis, streamlining workflows including scheduling, triage, and documentation, and improving outcomes by mining women’s health data to inform research and protocols.
Midi also highlighted outcomes it said are tied to its combination of clinical expertise, technology, and data, including a 28 percentage point increase in breast cancer screening adherence, an 11 percentage point increase in colorectal cancer screening adherence, and up to 13% lower total cost of care compared with a matched group. The company said it has also observed reductions in A1c and LDL levels in its patient data.
As it scales, Midi said it is adding senior leaders including Jason Wheeler as chief financial officer, Melissa Waters as chief marketing officer, and Matt Cook as chief commercial officer.
KEY QUOTES
“This is validation for the movement we’re leading to provide women better healthcare. Women’s health has been treated like an afterthought for too long. This funding gives us the resources to rewrite that story at scale.”
Joanna Strober, Co-Founder And Chief Executive Officer, Midi Health
“Goodwater is committed to Midi Health’s long-term mission to fundamentally transform women’s healthcare. Midi’s rise as the fastest-growing women’s health platform in the world is a testament to their entire care team, patient-centric approach, and AI advancements that deliver highly personalized care and scalable growth.”
Eric Kim, Co-Founder And Managing Partner, Goodwater Capital
“When women founders and women customers are heard, entire systems change. We have been following Joanna and the team for years and are impressed by the scale they have achieved. They are delivering care that’s critical for every woman to have access to, in a space that represents billions of dollars of healthcare spend.”
Serena Williams, Managing Partner, Serena Ventures
